Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway

por CHEN, ZHIGUANG, XUE, JINQI, SHEN, TAO, MU, SHUAI, FU, QIN
Publicado 2016

Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer

por Li, Jianyi, Jia, Shi, Zhang, Wenhai, Qiu, Fang, Zhang, Yang, Gu, Xi, Xue, Jinqi
Publicado 2015

Structure, Function, Diversity, and Composition of Fungal Communities in Rhizospheric Soil of Coptis chinensis Franch under a Successive Cropping System

por Alami, Mohammad Murtaza, Xue, Jinqi, Ma, Yutao, Zhu, Dengyan, Abbas, Aqleem, Gong, Zedan, Wang, Xuekui
Publicado 2020

Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer

por Shen, Yanyan, Xue, Jinqi, Yu, Jiahui, Jiang, Yi, Bu, Jiawen, Zhu, Tong, Gu, Xi, Zhu, Xudong
Publicado 2022

CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer

por Xing, Fei, Gao, Hongli, Chen, Guanglei, Sun, Lisha, Sun, Jiayi, Qiao, Xinbo, Xue, Jinqi, Liu, Caigang
Publicado 2023

Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application

por Gao, Hongli, Yin, Jianqiao, Ji, Ce, Yu, Xiaopeng, Xue, Jinqi, Guan, Xin, Zhang, Shuang, Liu, Xun, Xing, Fei
Publicado 2023

Advances in immunotherapy for triple-negative breast cancer

por Liu, Yang, Hu, Yueting, Xue, Jinqi, Li, Jingying, Yi, Jiang, Bu, Jiawen, Zhang, Zhenyong, Qiu, Peng, Gu, Xi
Publicado 2023

Correction: Advances in immunotherapy for triple-negative breast cancer

por Liu, Yang, Hu, Yueting, Xue, Jinqi, Li, Jingying, Yi, Jiang, Bu, Jiawen, Zhang, Zhenyong, Qiu, Peng, Gu, Xi
Publicado 2023

LIPH promotes metastasis by enriching stem‐like cells in triple‐negative breast cancer

por Zhang, Yixiao, Zhu, Xudong, Qiao, Xinbo, Gu, Xi, Xue, Jinqi, Han, Yanshuo, Sun, Lisha, Cui, Meizi, Liu, Caigang
Publicado 2020

Neoadjuvant Chemotherapy Plays an Adverse Role in the Prognosis of Grade 2 Breast Cancer

por Zhu, Xudong, Xue, Jinqi, Gu, Xi, Chen, Guanglei, Cao, Fangning, Shan, Huilian, Wang, Dan, Qiao, Xinbo, Liu, Caigang, Zhang, Yixiao
Publicado 2019

CEMIP as a potential biomarker and therapeutic target for breast cancer patients

por Xue, Jinqi, Zhu, Xudong, Qiao, Xinbo, Wang, Yulun, Bu, Jiawen, Zhang, Xiaoying, Ma, Qingtian, Liang, Lu, Sun, Lisha, Liu, Caigang
Publicado 2022

The altering in sensory sensitivity: a current issue of female breast surgery

por Zhu, Tong, Jiang, Yi, Liu, Ting, Xue, Jinqi, Niu, Nan, Bu, Jiawen, Liu, Mingxin, Liu, Caigang, Zhu, Xudong, Gu, Xi
Publicado 2022

KCNJ15 deficiency promotes drug resistance via affecting the function of lysosomes

por Qiao, Xinbo, Zhang, Yixiao, Zhang, Zhan, Niu, Nan, Li, Haonan, Sun, Lisha, Ma, Qingtian, Bu, Jiawen, Liu, Jinchi, Chen, Guanglei, Xue, Jinqi, Yang, Yongliang, Liu, Caigang
Publicado 2023

HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients

por Zhu, Xudong, Zhang, Yixiao, Bai, Yang, Gu, Xi, Chen, Guanglei, Sun, Lisha, Wang, Yulun, Qiao, Xinbo, Ma, Qingtian, Zhu, Tong, Bu, Jiawen, Xue, Jinqi, Liu, Caigang
Publicado 2020

Association of human breast cancer CD44(-)/CD24(-) cells with delayed distant metastasis

por Qiao, Xinbo, Zhang, Yixiao, Sun, Lisha, Ma, Qingtian, Yang, Jie, Ai, Liping, Xue, Jinqi, Chen, Guanglei, Zhang, Hao, Ji, Ce, Gu, Xi, Lei, Haixin, Yang, Yongliang, Liu, Caigang
Publicado 2021

KK-LC-1 as a therapeutic target to eliminate ALDH(+) stem cells in triple negative breast cancer

por Bu, Jiawen, Zhang, Yixiao, Wu, Sijin, Li, Haonan, Sun, Lisha, Liu, Yang, Zhu, Xudong, Qiao, Xinbo, Ma, Qingtian, Liu, Chao, Niu, Nan, Xue, Jinqi, Chen, Guanglei, Yang, Yongliang, Liu, Caigang
Publicado 2023

Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer

por Zhang, Yixiao, Sun, Lisha, Li, Haonan, Ai, Liping, Ma, Qingtian, Qiao, Xinbo, Yang, Jie, Zhang, Hao, Ou, Xunyan, Wang, Yining, Chen, Guanglei, Xue, Jinqi, Zhu, Xudong, Zhao, Yu, Yang, Yongliang, Liu, Caigang
Publicado 2022

A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer

por Niu, Nan, Qiu, Fang, Xu, Qianshi, He, Guijin, Gu, Xi, Guo, Wenbin, Zhang, Dianlong, Li, Zhigao, Zhao, Yi, Li, Yong, Li, Ke, Zhang, Hao, Zhang, Peili, Huang, Yuanxi, Zhang, Gangling, Han, Hongbin, Cai, Zhengang, Li, Pengfei, Xu, Hong, Chen, Guanglei, Xue, Jinqi, Jiang, Xiaofan, Jahromi, Alireza Hamidian, Li, Jinshi, Zhao, Yu, de Faria Castro Fleury, Eduardo, Huo, Shiwen, Li, Huajun, Jerusalem, Guy, Tripodi, Domenico, Liu, Tong, Zheng, Xinyu, Liu, Caigang
Publicado 2022